Evaluation and comparison of side effects of Pregabalin and Gabapentin in patients with Psychiatric disorders.

Phase 4

Recruiting

• Conditions: Condition 1: Anxiety disorder. Condition 2: Depressive disorder.; Anxiety disorder due to known physiological condition; Mood disorder due to known physiological condition with major depressive-like episode; F06.4; F06.32

• Registration Number: IRCT20100127003210N23
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

18 to 65 years old.
Suffering from depression or anxiety.
Taking Sertraline (50-100mg) or Citalopram (20-40mg) or Escitalopram (10mg).
Consent to enter the research.
Be married.

Exclusion Criteria

Refusing to fill the questionnaire.
Getting divorced or reaching menopause
Taking medications other than those listed.
Pregnancy or lactation.
Having substance abuse during the study.
Being allergic to Pregabalin or Gabapentin.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual Dysfunctions. Timepoint: One Month. Method of measurement: The International Index of Erectile function Questionnaire; The Female Sexual Function Index Questionnaire.;Drowsiness. Timepoint: One Month. Method of measurement: Questionnaire.;Dizziness. Timepoint: One Month. Method of measurement: Questionnaire.